Esperion Therapeutics, Inc. (NASDAQ:ESPR) Reported Basic Consolidated EPS Of $-2.2609 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Esperion Therapeutics, Inc. (NASDAQ:ESPR) for the period ended 2015-12-31 was $-2.2609. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $-2.2609.

EPS from continuing operations

Coming to basic EPS from continuing operations, Esperion Therapeutics, Inc. (NASDAQ:ESPR) reported $-2.2609 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $-2.2609.

EPS contribution from parent

For the annual period ended 2015-12-31, Esperion Therapeutics, Inc. (NASDAQ:ESPR) received basic EPS of $-2.2609 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $-2.2609.

Basic net EPS

For the annual period ended 2015-12-31, Esperion Therapeutics, Inc. (NASDAQ:ESPR) reported basic net EPS of $-2.26. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $-2.26.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $-2.2609. For the quarter ended 2015-12-31, consolidated diluted EPS was $-2.2609.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-2.2609 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $-2.2609.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $-2.26. For the quarterly period ended 2015-12-31, net diluted EPS was $-2.26.

Diluted EPS from parent

From the parent company, Esperion Therapeutics, Inc. (NASDAQ:ESPR) received diluted EPS of $-2.2609 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $-2.2609.

Esperion Therapeutics, Inc. (NASDAQ:ESPR) posted net basic EPS reading of $-2.26 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $-2.26 was for the quarter ended 2015-12-31.

Net diluted EPS for Esperion Therapeutics, Inc. (NASDAQ:ESPR) for the annual period ended 2015-12-31 was $-2.26. The company also reported net diluted EPS reading of $-2.26 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 22.02 while for the quarter ended 2015-12-31 is 22.02.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 22.02 while for the quarter ended 2015-12-31 is 22.02.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 16 times, 1 visits today)